Home > Cancer and Treatments >
Blood, Lymphatic & Bone Marrow Cancers
Moshe Talpaz, M.D., co-director
James L.M. Ferrara, M.D., co-director
Pavan Reddy, M.D., co-director
The Hematologic Malignancies-BMT Program has established multiple clinical care, basic, translational and clinical research collaborations that have been fostered by the
environment at the UMCCC. These efforts have led to several intra- and inter-programmatic projects that have resulted in federal and non-federal research
grants, clinical trial and translation research projects and enhanced patient care.
Over the past several years, our research has focused on improving effectiveness of how we treat lymphomas, leukemias and multiple myeloma. Drs. Jakubowiak and Talaz developed
a combination of therapies for both our newly diagnosed and progressive myeloma patients. Similarly, Drs. Bixby, Talpaz and Donato worked on combination therapy for
those with CML.
For detailed information on our research program, please visit: Hematologic Malignancies-BMT, part of our
Clinical Research Programs web page.
Still have questions?
The nurses at
Cancer AnswerLine™ have answers. Call 1-800-865-1125 and you'll get a personal response from one of our registered nurses,
who have years of experience in caring for people with cancer -- and keep up-to-date on research at the U-M Comprehensive Cancer Center.
